Literature DB >> 8213336

The association of age with the presentation and outcome of tuberculosis: a five-year survey.

C Teale1, J M Goldman, S B Pearson.   

Abstract

Of the 411 patients notified with tuberculosis in Leeds during 1986 through 1991, case notes were available on 406 (99%) and the diagnosis of mycobacterial disease was accepted in 397 (98%). Twenty-two patients had infection with atypical mycobacteria and were excluded from analysis, as were children under 16 years. Comparison between the age groups was further restricted to white patients because of a skew distribution of Asian patients towards the younger age range. Ninety-six elderly patients (aged 65 years and older) were compared with 127 younger patients. The distribution of pulmonary and extrathoracic disease was similar as was the incidence of positive bacteriology. Elderly people had more frequent lower-zone and more frequent miliary shadowing, otherwise radiographic features were similar. Elderly people were nearly three times more likely to have reactions to antituberculous drugs, six times more likely to die from tuberculosis and over twenty times more likely than younger patients to have the diagnosis made at autopsy rather than during life.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213336     DOI: 10.1093/ageing/22.4.289

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  20 in total

1.  Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs.

Authors:  Sophia B Georghiou; Marva Seifert; Donald G Catanzaro; Richard S Garfein; Timothy C Rodwell
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

2.  Mycobacterium tuberculosis at autopsy--exposure and protection: an old adversary revisited.

Authors:  R J Flavin; N Gibbons; D S O'Briain
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

Review 3.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Tuberculosis in ageing: high rates, complex diagnosis and poor clinical outcomes.

Authors:  Luis Pablo Cruz-Hervert; Lourdes García-García; Leticia Ferreyra-Reyes; Miriam Bobadilla-del-Valle; Bulmaro Cano-Arellano; Sergio Canizales-Quintero; Elizabeth Ferreira-Guerrero; Renata Báez-Saldaña; Norma Téllez-Vázquez; Ariadna Nava-Mercado; Luis Juárez-Sandino; Guadalupe Delgado-Sánchez; César Alejandro Fuentes-Leyra; Rogelio Montero-Campos; Rosa Areli Martínez-Gamboa; Peter M Small; José Sifuentes-Osornio; Alfredo Ponce-de-León
Journal:  Age Ageing       Date:  2012-03-19       Impact factor: 10.668

5.  Tuberculosis and poverty.

Authors:  M T Kearney; P D Warklyn; C Teale; J M Goldman; S B Pearson
Journal:  BMJ       Date:  1993-10-30

6.  TLR-2 independent recognition of Mycobacterium tuberculosis by CD11c+ pulmonary cells from old mice.

Authors:  Erin K Rottinghaus; Bridget Vesosky; Joanne Turner
Journal:  Mech Ageing Dev       Date:  2010-06-08       Impact factor: 5.432

Review 7.  Susceptibility of the aging lung to environmental injury.

Authors:  Lei Wang; Francis H Y Green; Suzette M Smiley-Jewell; Kent E Pinkerton
Journal:  Semin Respir Crit Care Med       Date:  2010-10-12       Impact factor: 3.119

8.  Diagnostic and therapeutic problems of pulmonary tuberculosis in elderly patients.

Authors:  Jae Ho Lee; Dae Hee Han; Jae Woo Song; Hee Soon Chung
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

9.  In-hospital mortality of disseminated tuberculosis in patients infected with the human immunodeficiency virus.

Authors:  Rodrigo Pires dos Santos; Caroline Deutschendorf; Karin Scheid; Luciano Zubaran Goldani
Journal:  Clin Dev Immunol       Date:  2010-08-04

10.  What happens to people diagnosed with tuberculosis? A population-based cohort.

Authors:  N Anyama; S Bracebridge; C Black; A Niggebrugge; S J Griffin
Journal:  Epidemiol Infect       Date:  2007-02-09       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.